-
Popular Links
-
Digestion
-
Hormones
-
Nutrition
-
Other
Your cart is currently empty!
£325.00
£325.00
The Comprehensive Stool Analysis with Parasitology and PCR evaluates the status of beneficial bacteria, imbalanced commensal bacteria, pathogenic bacteria, parasites and yeasts. If pathogenic cultures are identified, a sensitivity panel is provided to facilitate the selection of pharmaceutical or natural treatment agents. The efficiency of digestion and absorption is measured via faecal elastase, fat, carbohydrate, muscle and vegetable fibres whilst the biomarkers of calprotectin, lysozyme, lactoferrin, white blood cells and mucous can be used to assess inflammation. This can help to differentiate inflammation associated with inflammatory bowel disease (IBD) from that noted in irritable bowel syndrome (IBS). Humoral immune status of the gut is measured by secretory IgA (sIgA) while the assessment of short-chain fatty acids reflects overall gut health and microbiome balance. This profile is indicated for gastrointestinal symptoms, autoimmune disease, joint pain, IBD, IBS, inflammation, food sensitivities, nutritional deficiencies and skin conditions.
This test is carried out over one, two or three days depending on the needs of the practitioner or client.
The Comprehensive Stool Analysis with Parasitology and PCR evaluates the status of beneficial bacteria, imbalanced commensal bacteria, pathogenic bacteria, parasites and yeasts. If pathogenic cultures are identified, a sensitivity panel is provided to facilitate the selection of pharmaceutical or natural treatment agents. The efficiency of digestion and absorption is measured via faecal elastase, fat, carbohydrate, muscle and vegetable fibres whilst the biomarkers of calprotectin, lysozyme, lactoferrin, white blood cells and mucous can be used to assess inflammation. This can help to differentiate inflammation associated with inflammatory bowel disease (IBD) from that noted in irritable bowel syndrome (IBS). Humoral immune status of the gut is measured by secretory IgA (sIgA) while the assessment of short-chain fatty acids reflects overall gut health and microbiome balance. This profile is indicated for gastrointestinal symptoms, autoimmune disease, joint pain, IBD, IBS, inflammation, food sensitivities, nutritional deficiencies and skin conditions.
This test is carried out over one, two or three days depending on the needs of the practitioner or client.